National Research (NASDAQ:NRC) Stock Price Passes Above 200-Day Moving Average – Here’s Why

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $15.98 and traded as high as $17.59. National Research shares last traded at $17.34, with a volume of 60,208 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

National Research Trading Up 2.1%

The firm has a fifty day moving average of $16.04 and a 200 day moving average of $15.98. The firm has a market capitalization of $394.42 million, a PE ratio of 34.68 and a beta of 0.53. The company has a debt-to-equity ratio of 5.36, a quick ratio of 0.55 and a current ratio of 0.55.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.16 earnings per share for the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.The firm had revenue of $35.19 million during the quarter.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.7%. National Research’s dividend payout ratio is 128.00%.

Institutional Investors Weigh In On National Research

Large investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its stake in National Research by 9,535.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after buying an additional 1,621 shares during the period. Russell Investments Group Ltd. lifted its holdings in National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after buying an additional 921 shares in the last quarter. DGS Capital Management LLC purchased a new position in National Research in the 4th quarter valued at about $274,000. Morgan Dempsey Capital Management LLC purchased a new position in National Research in the 4th quarter valued at about $296,000. Finally, Copeland Capital Management LLC acquired a new stake in shares of National Research during the fourth quarter valued at about $65,000. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.